Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDA-MB231 human breast cancer cells

Nanomedicine (Lond). 2021 Aug;16(20):1763-1773. doi: 10.2217/nnm-2021-0066. Epub 2021 Jul 23.

Abstract

Aim: This study was aimed at evaluating the anticancer potential of curcumin-loaded poly(lactic-co-glycolic acid) (PLGA) based nanoparticles (NPs) in MDA-MB231 human breast cancer cells. Methods: Curcumin-loaded PLGA NPs were developed using a modified solvent evaporation technique. Physical characterization was performed on the formulated NPs. Furthermore, in vitro experiments were conducted to study the biological activity of the curcumin-loaded NPs. Results: Curcumin-loaded PLGA NPs demonstrated high encapsulation efficiency and sustained payload release. Moreover, the NPs exhibited a significant reduction in cell viability, cell migration and cell invasion in the MDA-MB231 cells. Conclusion: The study revealed that the formulated curcumin-loaded PLGA NPs possessed significant anti-metastatic properties. The findings showcased the possible potential of curcumin-loaded NPs in the management of debilitating conditions such as cancer. In addition, this study could form the basis for further research and advancements in this area.

Keywords: PLGA; anti-metastasis; curcumin; invasion; nanoparticles; solvent evaporation.

MeSH terms

  • Breast Neoplasms* / drug therapy
  • Cell Line, Tumor
  • Curcumin* / pharmacology
  • Drug Carriers
  • Female
  • Glycols
  • Humans
  • Nanoparticles*
  • Particle Size
  • Polylactic Acid-Polyglycolic Acid Copolymer

Substances

  • Drug Carriers
  • Glycols
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Curcumin